Ayako Tsuboya

Placebo-Controlled, Double-Blinded Phase III Study Comparing Dexamethasone on Day 1 With Dexamethasone on Days 1 to 3 With Combined Neurokinin-1 Receptor Antagonist and Palonosetron in High-Emetogenic Chemotherapy

Yuka Ito, Takashi Tsuda, Hiroko Minatogawa et al. · Journal of Clinical Oncology · 2018 · 72 citations

Medicine, Oncology, Pharmacology +11

Dexamethasone-sparing on days 2–4 with combined palonosetron, neurokinin-1 receptor antagonist, and olanzapine in cisplatin: a randomized phase III trial (SPARED Trial)

Hiroko Minatogawa, Naoki Izawa, Kazuhiro Shimomura et al. · British Journal of Cancer · 2023 · 15 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +6

Coadministration of cytotoxic chemotherapeutic agents with irinotecan is a risk factor for irinotecan-induced cholinergic syndrome in Japanese patients with cancer

Ayako Tsuboya, Ken‐ichi Fujita, Yutaro Kubota et al. · International Journal of Clinical Oncology · 2018 · 12 citations

Medicine, Oncology, Pharmacology +12

Medication Optimization Protocol Efficacy for Geriatric Inpatients

Kenya Ie, Masanori Hirose, Tsubasa Sakai et al. · JAMA Network Open · 2024 · 11 citations · Full text

Pharmacy, Geriatric Medicine, Pharmacotherapy +14

Minimal contribution of the hepatic uptake transporter OATP1B1 to the inter-individual variability in SN-38 pharmacokinetics in cancer patients without severe renal failure

Ayako Tsuboya, Yutaro Kubota, Hiroo Ishida et al. · Cancer Chemotherapy and Pharmacology · 2021 · 10 citations

Pharmacy, Pharmacokinetics, Pharmacology +16